SIO is pleased to provide its updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.
The Journal of the National Cancer Institute Monograph has published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.
Photo courtesy of Scottsdale Convention & Visitors Bureau
Thank You! We thank the more than 400 participants for making SIO's 15th International Conference, October 27-29, 2018 in Scottsdale, Arizona, so successful. We appreciate all the great converations and sharing of experience.
Please mark your calendars to join us for the 16th International Conference October 19-21, 2019 in New York, NY.
We are pleased to once again offer this widely attended Webinar, which originally aired in September. The webinar replay will be December 14, 2018 from 12:30-1:30 p.m. Eastern Time. Eugene Ahn, MD will be on hand to provide a live introduction and audience Q&A following Dr. Abrams' pre-recorded presentation.This webinar is free for SIO members and $20 for non-members. To register, click here
SIO2018 has wonderful opportunities for the integrative oncology patient advocate community.
For the first time, the SIO Annual Conference will host a Patient Advocate Opening Session prior to the start of the conference. This session will take place on Friday, October 26, 2018, from 4:00-5:30 pm MT and feature a presentation from Patient Advocate and creator of the blog Chemobrain: In the Fog, AnneMarie Ciccarella, an in-depth look at the SIO2018 program and which sessions will be best for patient advocates to attend presented by SIO Patient Advocate Task Force Chair, Betsy Glosik, as well as an opportunity to network with other patient advocates at the event. Be sure to RSVP to this session when you register!
Patients have the ability to play an important role in research. We will explore different and diverse tools necessary to ensure patient advocates are best equipped to have meaningful impact. From identifying opportunities where advocates may connect with researchers to finding appropriate training programs to learn best practices, different avenues will be explored. How to be most effective within research partnerships including the development of questions that matter to patients, setting up eligibility criteria, and helping with both trial accrual and dissemination of results will be discussed. In addition, we will investigate ways to best serve on peer review panels and advisory boards to bring the patient perspective into all aspects of clinical care.
About AnneMarie Ciccarella
AnneMarie Ciccarella, diagnosed with invasive breast cancer in 2006, is currently twelve years post-treatment. Presently with no evidence of disease, she launched a blog with the help of a writing program available to all patients and their loved ones at the cancer center where she was treated. Chemobrain: In The Fog, which she began writing to share her personal experiences of the daily challenges of living with chemobrain, changed the course of her life. She is currently a “care-helper” to her mom who is living with metastatic disease. Now involved in all sorts of advocacy efforts, AnneMarie has struggled with cognitive issues and hopes by continuing to share her story, she might help others. Actively involved with many cancer researchers, she strives to bring all patient concerns to the medical community. She is a graduate of Project LEAD, has mentored groups in AACR’s Scientist <-> Survivor Program, sits on peer review panels for the Department of Defense and the National Cancer Institute and is a member of the Digital Engagement Committee for SWOG. She also serves on the External Advisory Board at Lurie Cancer Center and is a patient partner advocate on a number of funded grants. Using integrative treatments alongside traditional medicine, her goal is to ensure that every person diagnosed with cancer, and their caregivers might achieve the best possible outcome from the moment of diagnosis and for the rest of their lives.
Interested in funding to help you attend SIO2018? There is potential SIO may be able to offer funding for Patient Advocates to attend SIO2018. For more information on eligibility and how to apply, click here.
SIO2018 will feature two luncheon presentations from Dugald Seely, ND, MSc, FABNO; and Tieraona Low Dog, MD.
The internet, social media, and cultural climate are rife with ultra-curt messages that are frequently one-sided and polarizing. In a noise-ridden and knowledge starved environment, how can integrative medicine cultivate a presence of trust, nuance and self-appraisal that sustains it and supports its growth amidst conspiracy thinking and harsh skepticism.
In this context, some questions are posed to enable a space of creative tension. What is the genius of integrative medicine and conversely its pitfalls and bugbears? What is the line between conspiracy and skepticism and how do we as clinicians and researchers create a thoughtful dialogue that supports positive change? What is positive change and who creates the dominant narrative? How do we stop our message from being lost, co-opted or negated to the point of invalidation? With a medical community still dominated by authoritarianism and ingrained biases, how can we create a boundary between beneficial and predatory medicine without falling prey to simple clichés or cynicism? An argument for rational critical appraisal will be raised with the goal of engaging our better selves and seeking this from others. In this, an exploration is made as to how we encourage patient advocacy, research, and diplomacy to gain a stronger foothold in the public consciousness and decision making venues related to health care.
About Dr. Seely
Dugald Seely is a naturopathic doctor and clinician scientist whose focus is on the application and evaluation of integrative oncology. Embodying a vibrant synthesis of evidence-based complementary medicine with conventional medicine, integrative oncology offers a path for improved clinical care that is obvious to the conscientious practitioner and that best supports patients in the way they most need. Dr. Seely seeks to build a richer integration of this medicine within the health care system as a respected path for practitioners and researchers and ultimately for patients to be best served.
Dr. Seely is the founder and executive director of the Ottawa Integrative Cancer Centre (OICC) and executive director for the department of research & clinical epidemiology at the Canadian College of Naturopathic Medicine. Dr. Seely is an affiliate investigator at the Ottawa Hospital Research Institute; Adjunct Professor with the Faculty of Medicine at the University of Ottawa; Integrative Oncology Section Editor for the journal Current Oncology; and Vice President of the Oncology Association of Naturopathic Physicians. In research, Dr. Seely has led numerous clinical studies and synthesis reviews having published over 70 peer-reviewed papers. Seely is a frequent speaker and is actively engaged in the research community through a number of associations. In clinic, Dr. Seely sees patients three days a week at the OICC and is thrilled to be able to combine his passion for research and in the service of the patients he cares for.
After Dr. Low Dog's presentation, participants will be able to:
About Dr. Low Dog
Tieraona Low Dog, M.D.’s exploration of natural medicine and its role in modern health care began more than 35 years ago as she studied midwifery, herbal medicine, massage therapy, and martial arts before earning her medical degree from the University of New Mexico School of Medicine.
Dr. Low Dog is an internationally recognized expert in the fields of integrative medicine, dietary supplements, herbal medicine and women’s health.
She has been an invited speaker to more than 550 scientific/medical conferences, published 40 peer-reviewed articles, written 20 chapters for medical textbooks, and has authored five books, including three National Geographic books, Fortify Your Life, Healthy at Home, and Life is Your Best Medicine. She recently founded her own natural medicine school, Medicine Lodge Ranch, which offers both digital and in-person courses with Dr. Low Dog.
Dr. Low Dog lives with her husband, horses, chickens, dogs, and cats on a small ranch in the mountains outside of Santa Fe, New Mexico.
For more information, see: www.DrLowDog.com/about.html
SIO2018 will include keynote presentations from Andrew Weil, MD; Patricia Ganz, MD; and Eran Ben-Ayre, MD.
Demand for practitioners of Integrative Oncology is high, motivated largely by awareness of the shortcomings of conventional cancer treatment. In the not-distant future, radiation therapy and chemotherapy will likely be obsolete, replaced by immunotherapy, gene therapy, antiangiogenesis therapy and other methods that better differentiate malignant cells from normal cells. The goals of IO should be: 1) to reduce the toxicity and increase the efficacy of conventional treatment, 2) to mobilize and enhance the body’s innate defenses in order to slow or halt progression of cancer and reduce risk of recurrence, and 3) to promote general health and improve overall quality of life.
In response to consumer demand for IO, many cancer treatment centers now advertise that they offer integrative care. Usually, what they offer are noncontroversial complementary services, such as nutritional counseling, massage, and stress management training. They are not willing to recommend or endorse the use of natural products like astragalus and Asian mushrooms, despite good evidence for safety and efficacy.
I will describe my experience at Beijing’s Guang’anmen Hospital, a modern medical center entirely devoted to Integrative Medicine, whose largest department is oncology. All cancer patients there are treated with surgery, radiation, and chemotherapy as indicated as well as nutritional therapy, massage, acupuncture and, especially, sophisticated Chinese herbal therapy to accomplish the important goals of IO.
Conventionally trained oncologists tend to reject much of this as lacking an evidence base or having the potential to cause harm or interfere with standard treatment. In addition to offering better, more comprehensive care to patients, we must work to broaden the training of oncologists.
About Dr. Weil
Andrew Weil, M.D., is a world-renowned leader and pioneer in the field of integrative medicine. Combining a Harvard education and a lifetime of practicing natural and preventive medicine, Dr. Weil is the founder and director of the University of Arizona Center for Integrative Medicine (AzCIM) in Tucson, where he also serves as a Clinical Professor of Medicine and Professor of Public Health as well as the Lovell-Jones Professor of Integrative Rheumatology.
He is a best-selling author of 15 books on healthy living, including the recent Mind Over Meds; Fast Food, Good Food; True Food; Spontaneous Happiness; Healthy Aging; and 8 Weeks to Optimum Health. Oxford University Press is currently producing the Weil Integrative Medicine Library, a series of volumes for clinicians in various medical specialties. The first of these, Integrative Oncology (co-edited with Dr. Donald Abrams) appeared in 2009 (2d. ed. 2014). Since 2009, Integrative Psychiatry, Integrative Pediatrics, Integrative Women’s Health (2d. ed. 2015), Integrative Rheumatology, Integrative Cardiology, Integrative Gastroenterology, Integrative Nursing, Integrative Men’s Health, Integrative Dermatology, Integrative Pain Management, Integrative Environmental Medicine, Integrative Preventive Medicine, and Integrative Psychiatry and Brain Health have been published. More volumes are in progress.
Dr. Weil also serves as the editorial director of drweil.com, the leading online resource for healthy living based on the philosophy of integrative medicine, and pens the popular Dr. Andrew Weil’s Self Healing monthly newsletter and a regular column in Prevention magazine. Dr. Weil is the founder and Chairman of the Weil Foundation, and the founder and co-Chairman of Healthy Lifestyle Brands. He is also a founder and partner of the growing group of True Food Kitchen restaurants. In 2017, he joined Seabourn and The Onboard Spa by Steiner in their “Spa and Wellness with Dr. Andrew Weil” mindful-living program, offered on all of its cruise ships.
Dr. Ganz will review information on the growing number of cancer survivors, and the evidence for the symptom burden associated with cancer treatments. Because there are now more than 15 million cancer survivors in the US, and nearly 30 million worldwide, understanding the biology and management of common symptoms is critical. She will focus on describing emerging evidence regarding the association of common symptoms of fatigue, insomnia and cognitive difficulties with treatment-associated inflammatory biology. Further, She will show research from her laboratory and others that find that various beneficial integrative oncology approaches are associated with improvements in inflammatory biology. Understanding the biological mechanisms underpinning common symptoms in cancer survivors is a first step in finding pharmacological and non-pharmacological approaches to their alleviation.
About Dr. Ganz
Patricia A. Ganz, MD, Distinguished Professor of Medicine at David Geffen School of Medicine and Professor of Health Policy & Management, Jonathan and Karin Fielding School of Public Health at UCLA; Director, Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
Patricia A. Ganz, M.D., a medical oncologist, has been a member of the faculty of the UCLA School of Medicine since 1978 and the UCLA School of Public Health since 1992. Since 1993 she has been the Director of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center. In 1999 she was awarded an American Cancer Society Clinical Research Professorship for “Enhancing Patient Outcomes across the Cancer Control Continuum.” Dr. Ganz was elected to the Institute of Medicine (IOM) in 2007, now National Academy of Medicine. She served on the National Cancer Institute Board of Scientific Advisors from 2002-2007 and on the American Society of Clinical Oncology (ASCO) Board of Directors from 2003-2006. She received the American Cancer Society Medal of Honor in 2010. Dr. Ganz is a pioneer in the assessment of quality of life in cancer patients, and has focused much of her clinical and research efforts in the areas of breast cancer and its prevention. At the Jonsson Comprehensive Cancer Center, she leads the scientific program focused on Patients and Survivors. Her major areas of research include cancer survivorship and the late effects of cancer treatment, measurement of patient-reported outcomes in clinical treatment trials, and quality of care for cancer patients. In July 2017, Dr. Ganz became Editor-in-Chief of the Journal of the National Cancer Institute (JNCI).
The Middle East is a unique setting in which one can explore the interchange between cross-cultural traditional medicine and supportive cancer care, especially within the context of integrative oncology. The diversity of Middle Eastern medical culture is particularly evident in Israel, where Arab and Islamic traditional herbal medicine – whose roots can be traced back to ancient Greek, Chinese, and Ayurvedic sources – interact with the Western-oriented approach of complementary medicine
The keynote lecture will present the phenomenon of an increasing interest in the field of integrative oncology in Israel and throughout the Middle East, which entails the designing of a patient-tailored and cultural-sensitive bio-psycho-social-spiritual model of holistic care. This approach is being examined within a pragmatic research design, in which the patient’s preference and health belief model plays an important role in the creation of a shared decision-making process, where the integrative physician and the patient co-establish treatment goals and program. The non-judgmental setting is also evidence-based, and is geared toward facilitating better communication with the patient’s oncology health care practitioners. The integrative oncology model needs to expand beyond the existing frameworks of complementary and traditional medicine, exploring the existence of synergy with other patient-centered medical disciplines such as palliative care and family medicine. It is with these goals in mind that a multi-national and interdisciplinary collaboration has been created, as part of the academic activities of the Middle-East Research Group in Integrative Oncology (MERGIO), within the Middle-East Cancer Consortium.
About Dr. Ben Arye
Eran Ben-Arye has an MD degree from the Faculty of Medicine of the Hebrew University of Jerusalem. He specialized in family medicine at the Department of Family Medicine, The Bruce Rappaport Faculty of Medicine, The Technion, Israel. Prof. Ben-Arye developed and instructed in a complementary medicine education program in the Division of Complementary Medicine, University of Maryland, Baltimore, USA. He is the co-founder and director of the Unit of Complementary and Traditional Medicine at the Department of Family Medicine, Haifa, and the director of the Integrative Oncology Program within the Haifa and Western Galilee Oncology Service, Lin Medical Center, Clalit Health Services. Prof. Ben-Arye is a Clinical Associate Professor at the Bruce Rappaport Faculty of Medicine, The Technion, and is a founding member and former Chairperson of the Israel Society for Complementary Medicine of the Israel Medical Association.
His research interests include integrative and complementary medicine, family medicine, integrative oncology, medical education, doctor-patient communication, evidence-based medicine and research, and traditional and cross-cultural medicine. He has authored and co-authored 140 manuscripts in peer-reviewed journals and 8 chapters in oncology textbooks. Prof. Ben-Arye has constructed and co-conducted more than 10 clinical studies in the area of complementary and integrative medicine, including three randomized controlled studies.
Professor Ben-Arye has been involved in promoting Integrative Oncology throughout the Middle East. Together with Professor Michael Silbermann, director of the Middle East Cancer Consortium (MECC), he co-founded the Middle-East Research Group in Integrative Oncology (MERGIO), regional, multi-national and interdisciplinary research collaboration.
Join us on Sunday, October 28 at the Desert Botanical Garden for an evening of fabulous food, drinks, an herb walk and entertainment from A 2nd Act! Please note: Tickets will NOT be sold on site this year and must be purchased in advance with conference registration.
Tickets for the SIO Gala Dinner are $150 and include:
Transportation for the Gala will leave the Scottsdale Resort at McCormick Ranch at 5:30 pm MT. The Gala will begin with a cocktail hour from 6:00 - 7:00 pm MT. This will be followed by a brief award ceremony, dinner, and entertainment from A 2nd Act. Transportation will depart the Desert Botanical Garden at 9:30 pm MT and stop in Old Town Scottsdale, then the Scottsdale Resort at McCormick Ranch. Those who get off the bus in Old Town Scottsdale will be required to find their own transportation back to the hotel (Uber, Lyft, Taxi, etc.).*
The dress code for this event is Busines and/or Cocktail attire. Please, no shorts or sandels. Becuase of the nature of the he surrounding environment please be sure to wear comfortable shoes.
If anyone is plannning on going out to to Old Town after the event, please make note you will need closed toe shows and long pants, no shorts are allowed.
More on the Desert Botanical Garden:
The Desert Botanical Garden is the southwest's largest botanical garden. Through permanent trailside exhibits, temporary art exhibitions and seasonal experiences they seek to transform the visitor experience into one of discovery and meaning about the desert and desert plants.
More on A 2nd Act:
*Exact schedule of events subject to change. Anyone who purchases a Gala ticket will be notified of any changes.